These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer. Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387 [TBL] [Abstract][Full Text] [Related]
3. Co-activator SRC-1 is dispensable for transcriptional control by STAT3. Cvijic H; Bauer K; Löffler D; Pfeifer G; Blumert C; Kretzschmar AK; Henze C; Brocke-Heidrich K; Horn F Biochem J; 2009 Apr; 420(1):123-32. PubMed ID: 19203349 [TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway. Fang P; Hwa V; Rosenfeld RG Exp Cell Res; 2006 May; 312(8):1229-39. PubMed ID: 16427044 [TBL] [Abstract][Full Text] [Related]
5. BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription. Brocke-Heidrich K; Ge B; Cvijic H; Pfeifer G; Löffler D; Henze C; McKeithan TW; Horn F Oncogene; 2006 Nov; 25(55):7297-304. PubMed ID: 16732314 [TBL] [Abstract][Full Text] [Related]
6. Physical and functional interactions between STAT3 and ZIP kinase. Sato N; Kawai T; Sugiyama K; Muromoto R; Imoto S; Sekine Y; Ishida M; Akira S; Matsuda T Int Immunol; 2005 Dec; 17(12):1543-52. PubMed ID: 16219639 [TBL] [Abstract][Full Text] [Related]
7. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines. Gu L; Chiang KY; Zhu N; Findley HW; Zhou M Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050 [TBL] [Abstract][Full Text] [Related]
8. Association and contribution of ERK to IL-6-induced activation of signal transducer and activator of transcription in a human myeloma cell line. Song L; Shen B; Li Y Chin Med J (Engl); 2001 Sep; 114(9):954-7. PubMed ID: 11780390 [TBL] [Abstract][Full Text] [Related]
9. Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity. Thyrell L; Arulampalam V; Hjortsberg L; Farnebo M; Grandér D; Pokrovskaja Tamm K Exp Cell Res; 2007 Nov; 313(19):4015-24. PubMed ID: 17880940 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line. Gariboldi MB; Ravizza R; Molteni R; Osella D; Gabano E; Monti E Cancer Lett; 2007 Dec; 258(2):181-8. PubMed ID: 17920763 [TBL] [Abstract][Full Text] [Related]
11. The effect of azacitidine on interleukin-6 signaling and nuclear factor-kappaB activation and its in vitro and in vivo activity against multiple myeloma. Khong T; Sharkey J; Spencer A Haematologica; 2008 Jun; 93(6):860-9. PubMed ID: 18443271 [TBL] [Abstract][Full Text] [Related]
12. REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells. Sekikawa A; Fukui H; Fujii S; Ichikawa K; Tomita S; Imura J; Chiba T; Fujimori T Carcinogenesis; 2008 Jan; 29(1):76-83. PubMed ID: 18024479 [TBL] [Abstract][Full Text] [Related]
13. STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes. Krejci P; Salazar L; Goodridge HS; Kashiwada TA; Schibler MJ; Jelinkova P; Thompson LM; Wilcox WR J Cell Sci; 2008 Feb; 121(Pt 3):272-81. PubMed ID: 18198189 [TBL] [Abstract][Full Text] [Related]
14. EGF-induced apoptosis in A431 cells is dependent on STAT1, but not on STAT3. Grudinkin PS; Zenin VV; Kropotov AV; Dorosh VN; Nikolsky NN Eur J Cell Biol; 2007 Oct; 86(10):591-603. PubMed ID: 17646016 [TBL] [Abstract][Full Text] [Related]
15. A link between the interleukin-6/Stat3 anti-apoptotic pathway and microRNA-21 in preimplantation mouse embryos. Shen XH; Han YJ; Zhang DX; Cui XS; Kim NH Mol Reprod Dev; 2009 Sep; 76(9):854-62. PubMed ID: 19437447 [TBL] [Abstract][Full Text] [Related]
16. An RNA biding protein, Y14 interacts with and modulates STAT3 activation. Ohbayashi N; Taira N; Kawakami S; Togi S; Sato N; Ikeda O; Kamitani S; Muromoto R; Sekine Y; Matsuda T Biochem Biophys Res Commun; 2008 Aug; 372(3):475-9. PubMed ID: 18503751 [TBL] [Abstract][Full Text] [Related]
17. Cyclophilin A as a downstream effector of PI3K/Akt signalling pathway in multiple myeloma cells. Lin ZL; Wu HJ; Chen JA; Lin KC; Hsu JH Cell Biochem Funct; 2015 Dec; 33(8):566-74. PubMed ID: 26833980 [TBL] [Abstract][Full Text] [Related]
18. Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN. Heo JY; Kim HJ; Kim SM; Park KR; Park SY; Kim SW; Nam D; Jang HJ; Lee SG; Ahn KS; Kim SH; Shim BS; Choi SH; Ahn KS Cancer Lett; 2011 Sep; 308(1):71-80. PubMed ID: 21565443 [TBL] [Abstract][Full Text] [Related]
19. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity. Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108 [TBL] [Abstract][Full Text] [Related]
20. Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix. Allain F; Vanpouille C; Carpentier M; Slomianny MC; Durieux S; Spik G Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2714-9. PubMed ID: 11867726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]